###begin article-title 0
###xml 24 28 24 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 18 23 <span type="species:ncbi:9606">human</span>
Regulation of the human LAT gene by the Elf-1 transcription factor
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
The LAT gene encodes an intracellular adaptor protein that links cell-surface receptor engagement to numerous downstream signalling events, and thereby plays an integral role in the function of cell types that express the gene, including T cells, mast cells, natural killer cells, and platelets. To date, the mechanisms responsible for the transcriptional regulation of this gene have not been investigated.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 75 79 75 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 435 439 435 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 69 74 <span type="species:ncbi:9606">human</span>
In this study we have mapped the transcriptional start sites for the human LAT gene and localized the 5' and 3' boundaries of the proximal promoter. We find that the promoter contains both positive and negative regulatory regions, and that two binding sites for the Ets family of transcription factors have a strong, positive effect on gene expression. Each site binds the Ets family member Elf-1, and overexpression of Elf-1 augments LAT promoter activity. The promoter also contains a Runx binding site adjacent to one of the Ets sites. This site, which is shown to bind Runx-1, has an inhibitory effect on gene expression. Finally, data is also presented indicating that the identified promoter may regulate cell-type specific expression.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 98 102 98 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
Collectively, these results provide the first insights into the transcriptional regulation of the LAT gene, including the discovery that the Ets transcription factor Elf-1 may play a central role in its expression.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 369 370 361 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 371 372 363 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 660 661 648 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 662 663 650 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
The LAT gene encodes a 36-38 kD transmembrane protein that connects various cell surface receptors to downstream signaling events. Following receptor engagement, LAT becomes heavily tyrosine phosphorylated and subsequently binds a number of proteins containing SH2 domains, including members of the Grb2 family (Grb2, Gads, Grap) and phospholipase C-gamma (PLC-gamma) [1,2]. The interaction of Grb2, PLC-gamma and other proteins with LAT facilitates their activation and leads to additional biochemical events required for a productive cellular response, including activation of the Ras-MAPK signaling pathway and an elevation in intracellular calcium levels [1,2].
###end p 9
###begin p 10
###xml 105 106 105 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 107 108 107 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 245 249 245 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 255 256 255 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 257 258 257 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 510 511 510 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 898 899 898 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 900 902 900 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1069 1071 1069 1071 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1072 1074 1072 1074 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 415 419 <span type="species:ncbi:10090">mice</span>
One receptor type whose engagement results in LAT tyrosine phosphorylation is the T cell receptor (TCR) [3,4]. The essential role of LAT in TCR signaling has been revealed through the study of mutant Jurkat T cell lines that fail to express the LAT gene [5,6]. These LAT-deficient T cells display a number of signaling defects that prevent T cell activation and effector cell function. An analysis of LAT-deficient mice has also shown that the LAT protein is necessary for T cell maturation within the thymus [7]. In addition to its requirement for T cell development and function, LAT has important roles in other cell-types. For example, LAT is required for mast cell activation following engagement of the high affinity receptor for immunoglobulin E, for Natural Killer (NK) cell-mediated cytotoxicity, and for collagen, collagen-related peptide, and convulxin-mediated activation of platelets [8-12]. Moreover, engagement of the pre-B cell receptor on developing B cells induces LAT tyrosine phosphorylation, an event that may contribute to B cell differentiation [13-15].
###end p 10
###begin p 11
###xml 88 92 88 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 292 293 292 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 294 295 294 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 296 298 296 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 351 355 351 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 496 497 496 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 498 499 498 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 500 502 500 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 505 509 505 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 650 652 650 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 653 655 653 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
The identified role of LAT in these cell-types is reflective of its expression pattern. LAT RNA and/or protein has been detected in the thymus, spleen, and peripheral blood cells but is absent in the colon, brain, small intestine, ovary, testis, prostate, kidney, skeletal muscle, and liver [3,4,16]. Examination of specific cell-types indicates that LAT gene expression is restricted to a subset of cell-types generated during hematopoiesis, namely T cells, mast cells, platelets, and NK cells [3,4,16]. LAT is also expressed at low levels during the early stages of B cell development and is subsequently down-regulated prior to B cell maturation [14,15].
###end p 11
###begin p 12
###xml 32 36 32 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 181 185 181 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 599 603 599 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 729 733 729 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 870 874 870 874 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 978 982 978 982 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 175 180 <span type="species:ncbi:9606">human</span>
To date, the means by which the LAT gene is transcriptionally regulated has not been investigated. In the present work, we have mapped the transcriptional start sites for the human LAT gene and localized the proximal promoter region to approximately 800 bp extending upstream of the translation start site. Within the promoter, we have identified a negative regulatory region and two Ets binding sites that are bound by the Elf-1 transcription factor. Mutation of these Ets sites significantly reduces promoter activity, and consistent with these findings, overexpression of Elf-1 potently enhances LAT promoter function. A Runx binding site is also identified that binds Runx-1, and which when mutated results in an increase in LAT promoter activity. The data presented also suggests that the identified promoter region may mediate cell-type specific expression of the LAT gene. Collectively, these results provide the first insights into the transcriptional regulation of the LAT gene, which encodes an essential adaptor protein linking cell-surface receptors to critical downstream signaling events.
###end p 12
###begin title 13
Results
###end title 13
###begin title 14
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
The LAT gene contains multiple transcription start sites
###end title 14
###begin p 15
###xml 69 73 69 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 139 143 139 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 394 396 394 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 397 399 397 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 435 439 435 437 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 547 551 545 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 724 725 722 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 1261 1263 1259 1261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 133 138 <span type="species:ncbi:9606">human</span>
###xml 266 271 <span type="species:ncbi:9606">human</span>
###xml 814 819 <span type="species:ncbi:9606">human</span>
As an initial step in the identification and characterization of the LAT promoter, we mapped the transcription start site(s) for the human LAT gene using RNA ligase-mediated rapid amplification of cDNA ends (RLM-RACE) and poly(A) RNA isolated from Jurkat T cells or human thymus. The products of RLM-RACE, which are only derived from RNA transcripts extending to the terminal 5' cap structure [17,18], were ligated into the pBluescript(R) vector and 15 of the resulting clones from each source of RNA were sequenced. The results indicate that the LAT gene possesses multiple transcription start sites that lie in a region spanning roughly 75 bp and located between 250 to 335 bp upstream of the translation start site (Fig. 1). The transcription start sites mapped to the same general region in Jurkat T cells and human thymus, and in many cases the same sites were utilized. Analysis of the DNA sequence surrounding the transcription start sites revealed that the region is G/C-rich but lacks consensus sites for either a TATA box or initiator elements. Similar to this situation, it has been observed that other G/C-rich promoters which lack a TATA box or initiator elements also possess multiple transcription start sites that span regions of 75 bp or more [19].
###end p 15
###begin title 16
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
The LAT promoter extends 800 bp upstream of the translation start site
###end title 16
###begin p 17
###xml 828 830 828 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 1402 1404 1402 1404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
To ascertain whether regions 5' and 3' of the transcription start sites possess promoter activity, a DNA fragment extending 1200 bp upstream from the translation start site was amplified by PCR and inserted adjacent to the firefly luciferase gene in the pGL3-basic vector. Of note, in this study the 'A' nucleotide of the translation start site ATG codon has been designated +1. Thus, the transcription start sites lie in the region from -335 to -250 and the 1200 bp fragment extends from -1200 to -1. Transient transfection into Jurkat T cells with the luciferase reporter construct containing the -1200 to -1 DNA fragment resulted in a greater than 10-fold increase in luciferase activity relative to the empty, promoterless pGL3-basic vector, demonstrating that this DNA fragment contains significant promoter activity (Fig. 2A). In order to more precisely map the boundaries of the promoter, sequential 5' and 3' deletions of 200 bp were introduced and the effect on promoter activity was determined in Jurkat cells. Deletion of the region from -1200 to -800 did not have an appreciable effect on promoter activity. However, deletion of the region from -800 to -600 resulted in a decrease in promoter activity, and a further decrease was observed when the region from -600 to -400 was removed. Finally, when the -400 to -200 region was deleted, promoter activity dropped to background levels (Fig. 2A).
###end p 17
###begin p 18
###xml 160 162 160 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 283 285 283 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 395 396 395 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 469 473 469 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
Surprisingly, when the 3' 200 bp was removed from the -1000 to -1 promoter fragment (-1000 to -200), a substantial increase in promoter activity occurred (Fig. 2B). However, removal of an additional 200 bp from the 3' end (-1000 to -400) completely abrogated promoter activity (Fig. 2B). This latter result is most likely a consequence of eliminating all the transcription start sites (see Fig. 1). In summary, these results indicate that the proximal promoter for the LAT gene lies in a region extending from -800 to -1 relative to the translation start site, with the region from -800 to -200 having an overall stimulatory effect on promoter activity while the region from -200 to -1 has an inhibitory effect.
###end p 18
###begin p 19
###xml 29 33 29 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 170 172 170 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 453 455 453 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 664 666 664 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 839 843 839 843 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 1082 1084 1082 1084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2D</xref>
###xml 833 838 <span type="species:ncbi:9606">human</span>
In this initial study of the LAT promoter, we chose to focus on the region spanning from -600 to -200 since it contained a significant portion of promoter activity (Fig. 2A). To more precisely map the positive regulatory elements within this region, a series of sequential 50 bp deletions from the 5' end of the -600 to -1 fragment were created and the resultant promoter activity of each DNA fragment was determined in Jurkat T cells. As shown in Fig. 2C, deletion of the region from -600 to -450 did not result in a significant loss in promoter function. In contrast, deletion of the region from -450 to -350 reduced promoter activity to background levels (Fig. 2C). These results indicate that the region spanning from -450 to -350 contains a substantial portion of the positive regulatory elements mediating transcription of the human LAT gene. Consistent with these data, a DNA fragment spanning from -450 to -300, which contains the -450 to -350 stimulatory region and a number of transcription start sites found between -350 to -300, displayed robust promoter activity (Fig. 2D).
###end p 19
###begin title 20
###xml 66 70 66 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
Linker scanning mutagenesis of the -450 to -350 region within the LAT promoter
###end title 20
###begin p 21
###xml 129 134 129 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NotI </italic>
###xml 287 289 287 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 294 296 294 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 459 461 459 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
Linker scanning mutagenesis throughout the -450 to -350 region, conducted by introducing sequential 10 bp mutations containing a NotI restriction site sequence, was performed with the -1000 to -1 promoter fragment and the effects on promoter activity were tested in Jurkat T cells (Fig. 3A and 3B). Each 10 bp mutation resulted in a decrease in promoter activity, with the most dramatic reduction occurring when the region from -390 to -350 was altered (Fig. 3B).
###end p 21
###begin p 22
###xml 326 331 326 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NheI </italic>
###xml 469 471 469 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
To ensure that the effects observed in the linker scanning mutagenesis experiments were not an artifact of the introduced sequence, we also constructed an additional set of linker scanning mutations throughout the -400 to -350 region, sequentially mutating the same 10 bp segments except introducing a sequence containing the NheI restriction site. Transient transfection of these reporter constructs in Jurkat T cells yielded results similar to those obtained in Fig. 3B except for the region spanning from -380 to -371, which when mutated in this latter set of experiments yielded only a ~50% decrease in promoter function (data not shown).
###end p 22
###begin p 23
###xml 131 135 131 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
Collectively, the data from linker scanning mutagenesis indicates that the entire region from -450 to -350 is required for optimal LAT promoter activity in Jurkat T cells, with DNA sequences from -390 to -350 having the most prominent role.
###end p 23
###begin title 24
###xml 31 35 31 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
Two Ets sites are required for LAT promoter activity
###end title 24
###begin p 25
###xml 118 121 118 119 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174;</sup>
###xml 149 151 147 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 152 154 150 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 334 335 332 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 338 340 336 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 341 343 339 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 601 605 599 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 611 613 609 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 614 616 612 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
Analysis of the -450 to -350 region using a variety of transcription factor binding site databases, including TRANSFAC(R), JASPAR, and MatInspector [20-22], revealed a number of possible regulatory elements, including two sites that contain the core binding sequence (5'-TTCC-3') for the Ets family of transcription factors (see Fig. 1) [23-26]. These potential Ets sites, which lie within the critical -390 to -350 region, were of particular interest in light of the well-documented role Ets transcription factors play in the development and function of T cells and other cell types that express the LAT gene [24-26].
###end p 25
###begin p 26
###xml 77 81 77 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 158 159 158 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 376 377 376 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 606 610 606 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
To determine the function of each putative Ets site in the regulation of the LAT promoter, point mutations were introduced into each of these sites (see Fig. 1) in the context of the -1000 to -1 promoter fragment and the effect of each mutation was determined in Jurkat T cells. When either Ets site was mutated, a significant decrease in promoter activity was observed (Fig. 4). Furthermore, simultaneous deletion of both Ets sites resulted in a level of promoter activity less than when either site alone was mutated. These data demonstrate that both putative Ets sites have a strong, positive effect on LAT promoter function in T cells.
###end p 26
###begin title 27
Both Ets sites bind Elf-1, a member of the Ets transcription factor family
###end title 27
###begin p 28
###xml 141 143 141 143 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 420 422 420 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
Electrophoretic mobility shift assays (EMSAs) were used to identify protein complexes that specifically bind each of the putative Ets sites. 32P labeled DNA probes encompassing each Ets site were incubated with nuclear extracts from Jurkat T cells and then analyzed by nondenaturing polyacrylamide gel electrophoresis and autoradiography. Two major complexes were detected binding to the Ets site centered at -360 (Fig. 5A). One of these complexes was competed for with a 100-fold excess of unlabeled wild-type probe (self wt) but was not competed for when the Ets site was mutated (self mutEts), demonstrating that this complex specifically interacted with the Ets site. Of note, the mutant probe used in these competition experiments contained the same bp changes as those introduced into the Ets site in the promoter construct used in transient transfections.
###end p 28
###begin p 29
###xml 215 217 215 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 730 732 730 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 904 908 904 908 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 914 916 914 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 917 919 917 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1195 1197 1195 1197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 1202 1204 1202 1204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5C</xref>
###xml 1394 1396 1394 1396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 1867 1871 1867 1871 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 574 579 <span type="species:ncbi:9606">human</span>
Additional competition experiments were performed with an unlabeled probe containing a consensus Ets site (cons. wt) or the same probe except that the Ets site was disrupted by a point mutation (cons. mutEts) (Fig. 5A). The loss of binding in the presence of the consensus wild-type Ets sequence but not with the mutated sequence suggested that the specific complex contains members of the Ets family of transcription factors. In an effort to identify the particular Ets family members capable of binding the -360 Ets site, we performed antibody supershift experiments. The human genome contains 27 genes that encode members of the Ets family of transcription factors, 16 of which have been shown to be expressed in Jurkat cells [27]. We chose to focus on Ets-1, Ets-2, Elf-1, and Fli-1, Ets family members implicated in the regulation of gene expression in T cells and other cell types that express the LAT gene [23-26]. Although addition of antibodies to Ets-2 or Fli-1 had no discernible effect, in the presence of the Elf-1 antibody a significant decrease in the intensity of the specific complex was observed, and upon longer exposure of the gel, supershifted complexes were detected (Fig. 5B and 5C). It was also evident upon addition of the Elf-1 antibody that the specific complex contains at least two distinguishable bands, one of which appears unaffected by the Elf-1 antibody (Fig. 5B). Finally, in the presence of the Ets-1 antibody, a novel slower mobility band appeared. Although the appearance of this band was not accompanied by an appreciable decrease in the intensity of the specific complex, it is known that antibodies to Ets-1 can enhance its DNA binding capability, and thus we can not presently exclude the possibility that Ets-1 may also bind to this site in the LAT promoter. In summary, these results indicate that the -360 Ets site in the LAT promoter is capable of binding the Ets transcription factor Elf-1, and also possibly Ets-1.
###end p 29
###begin p 30
###xml 93 95 93 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 478 480 478 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 1063 1065 1063 1065 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
###xml 1146 1150 1146 1150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
When the Ets site centered at -390 was examined by EMSA, three complexes were detected (Fig. 6A). Two of these complexes were competed for with a 100-fold excess of unlabeled wild-type probe, but not when the Ets site was mutated, demonstrating that the binding of these complexes required an intact Ets site. When the consensus Ets site was used in competition experiments, the more prominent specific complex was competed for while the less prominent one was unaffected (Fig. 6A), suggesting that the more prominent complex contains Ets family members. The composition of the less prominent complex is uncertain at this time but may contain a transcription factor that binds to a site that overlaps the Ets site. In supershift experiments, addition of antibodies to Ets-1, Ets-2, and Fli-1 had no appreciable effect on the specific complexes, but when the Elf-1 antibody was added to the binding reaction an almost complete loss of the most prominent complex was observed, and this was accompanied by the appearance of slower mobility, supershifted bands (Fig. 6B). These data demonstrate that Elf-1 is capable of binding both Ets sites in the LAT promoter.
###end p 30
###begin title 31
###xml 18 22 18 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
Activation of the LAT promoter by overexpression of Elf-1
###end title 31
###begin p 32
###xml 68 72 68 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 243 247 243 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 387 389 387 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 390 392 390 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 532 534 532 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 535 537 535 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 653 654 653 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 749 750 749 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 1160 1161 1160 1161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 1270 1274 1270 1274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
To further explore the potential role of Elf-1 in the regulation of LAT gene expression, overexpression studies were conducted. Preliminary experiments were performed in Jurkat T cells and failed to reveal an effect of Elf-1 overexpression on LAT promoter activity (data not shown), a result likely attributable to the high endogenous levels of this transcription factor in these cells [27,28]. We therefore used HeLa cells for these experiments, which in contrast to Jurkat T cells express low to undetectable levels of the Elf-1 [27-29]. Overexpression of Elf-1 in HeLa cells resulted in a greater than 10-fold increase in LAT promoter activity (Fig. 7). Of note, identical results were obtained when either the -400 to -1 promoter fragment (Fig. 7) or the -1000 to -1 promoter fragment (data not shown) were used. To determine whether the observed activation by Elf-1 occurred through the Ets sites centered at -360 and -390, Elf-1 was overexpressed in the presence of the promoter construct containing point mutations in both these sites. Mutation of the Ets sites resulted in dramatic decrease in the ability of Elf-1 to stimulate promoter function (Fig. 7), results that clearly demonstrate Elf-1 can stimulate gene expression through both of the Ets sites in the LAT promoter.
###end p 32
###begin title 33
###xml 12 16 12 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
Role of the LAT promoter in cell-type specific expression
###end title 33
###begin p 34
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 124 125 124 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 126 127 126 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 128 130 128 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 169 173 169 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 335 339 335 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 444 448 444 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 555 556 555 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 557 559 557 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
The LAT gene is expressed in T cells, NK cells, mast cells, platelets, and developing B cells but not in other cells types [3,4,16] To explore the potential role of the LAT promoter in mediating cell-type specific gene expression, we investigated promoter activity in various cell-types that either do or do not express the endogenous LAT gene. In addition to Jurkat T cells, the RBL-2H3 mast cell line has been shown to express the endogenous LAT gene while the HeLa epithelial cell line, the 70Z pre-B cell line, and the Raji mature B cell line do not [3,15]. Reporter vectors containing LAT promoter fragments of various lengths were transfected into each of these cell-types and following incubation the cells were harvested and promoter activity quantitated.
###end p 34
###begin p 35
###xml 45 49 45 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 191 193 191 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8A</xref>
###xml 492 496 492 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 703 707 703 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 790 794 790 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 927 931 927 931 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 295 299 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
In addition to Jurkat cells, the -1000 to -1 LAT promoter fragment displayed significant activity in RBL-2H3 and HeLa cells but was relatively inactive in the 70Z and Raji B cell lines (fig. 8A). Experiments were also conducted in each cell line using the pGL3-control vector which contains the SV40 promoter and enhancer. The average fold activation for the pGL3-control vector was 50.1 for 70Z, 245.2 for Raji, 110.3 for RBL-2H3, and 300.6 for HeLa, indicating that the lack of appreciable LAT promoter function in 70Z and Raji cell lines is not a consequence of low transfection efficiencies. These data suggest that the lack of promoter activity in 70Z and Raji cells may explain why the endogenous LAT gene is not expressed in these cell-types. However, additional means of inhibiting LAT gene expression likely exist since the promoter retained activity HeLa cells, another cell-type that fails to express the endogenous LAT gene.
###end p 35
###begin p 36
###xml 157 159 157 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8A</xref>
###xml 353 357 353 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 730 732 730 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8B</xref>
###xml 798 802 798 802 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
In contrast to results obtained in Jurkat T cells, a promoter fragment spanning from -400 to -1 was unable to support gene expression in RBL-2H3 cells (Fig. 8A). This result implies that this region of the promoter may operate differently in these two cells-types, and it was conceivable that the Ets sites located at -360 and -390 do not contribute to LAT promoter activity in mast cells. In order to determine the role of the Ets sites in mast cells, we tested the activity of the -1000 to -1 promoter fragment in the absence or presence of mutations in each site. Our results found that mutation of either Ets site caused a reduction in promoter activity, and a further decrease was seen when both Ets sites were mutated (Fig. 8B). Thus, the Ets sites centered at -360 and -390 are required for LAT promoter function in both Jurkat T cells and RBL-2H3 mast cells.
###end p 36
###begin p 37
###xml 379 381 379 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8C</xref>
###xml 493 495 493 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 563 567 563 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
We also explored whether the inhibitory region spanning from -200 to -1 may be more active in mast cells since this could also explain why the -400 to -1 region was unable to support gene expression in RBL-2H3 cells. When the -1000 to -200 promoter construct was transfected into RBL-2H3 cells, promoter activity increased over 6-fold relative to the -1000 to -1 construct (Fig. 8C). When similar experiments were conducted in Jurkat cells, an approximately 3-fold increase was observed (Fig. 2B). Thus, the greater suppressive effect of the -200 to -1 region on LAT promoter activity in RBL-2H3 cells may provide one explanation why the -400 to -1 region lacks activity in this cell line.
###end p 37
###begin title 38
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
The LAT promoter contains a potential Runx binding site adjacent to the Ets site centered at -360
###end title 38
###begin p 39
###xml 23 27 23 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 114 118 114 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 518 520 514 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 521 523 517 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 785 787 781 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 788 790 784 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 1141 1143 1137 1139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1144 1146 1140 1142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 1147 1149 1143 1145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 1289 1293 1285 1289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 17 22 <span type="species:ncbi:9606">human</span>
###xml 108 113 <span type="species:ncbi:10090">mouse</span>
Alignment of the human LAT promoter sequence with the region upstream of the translation start site for the mouse LAT gene revealed that the Ets sites are 100% conserved between the two species. Interestingly, sequences adjacent to the Ets sites are also conserved, and close inspection of the region 5' of the Ets site centered at -360 revealed a potential binding site for the Runx family of transcription factors. The Runx family, also called CBFalpha, AML, or PEBP2, consists of three members: Runx-1, -2, and -3 [30,31]. These transcription factors contain a conserved 128 amino acid DNA binding domain that interacts with the consensus sequence 5'-ACCPuCA-3', and they can either activate or repress gene expression depending on the context of the specific promoter or enhancer [30,31]. Interestingly, in a number of instances Runx and Ets binding sites have been found adjacent to one another in gene regulatory regions. Moreover, it has been shown that one Runx family member, Runx-1, can physically interact with certain Ets proteins, resulting in cooperative DNA binding and thereby facilitating the activation of gene expression [30,32-38]. It was therefore conceivable that in a manner similar to other regulatory regions, Runx-1 and Ets proteins cooperatively interact at the LAT promoter to activate gene expression.
###end p 39
###begin p 40
###xml 126 130 126 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 163 165 163 165 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 294 295 294 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 314 316 314 316 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 534 536 534 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9A</xref>
###xml 943 945 943 945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8A</xref>
###xml 1462 1464 1462 1464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9B</xref>
As a first step in testing this possibility, EMSA was used to determine if Runx-1 could bind to the putative Runx site in the LAT promoter. In these experiments a 32P labeled probe encompassing both the Runx site and the adjacent Ets site at -360 was used, in contrast to results shown in Fig. 5 in which case the 32P labelled probe contained the Ets site but not the Runx site. In the presence of Jurkat nuclear extracts, a complex formed that contained a diffuse band that extended above and below a more defined central band (Fig. 9A). Both the diffuse and central band were effectively competed for by an excess of unlabeled wild-type probe. When the unlabeled competitor contained a mutation in the Ets site, the diffuse band was competed for but the more defined central band was not. Conversely, when the unlabeled competitor contained a mutation in the Runx site, the central band was competed for but not the more diffuse band. (Fig. 8A). Finally, when the unlabeled competitor contained a mutation in both the Runx and Ets sites, no bands were competed. Taken together, these results demonstrate that the diffuse band represents proteins specifically interacting with the Runx site while the more defined central band represents proteins specifically binding to the Ets site. Of note, the prominent central band that remained in the presence of the competitor containing a mutation in the Ets site could be supershifted with an antibody to Elf-1 (Fig. 9B), which is consistent with our earlier data identifying Elf-1 as the major Ets family member binding to this site.
###end p 40
###begin p 41
###xml 303 305 303 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9C</xref>
###xml 346 350 346 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 433 437 433 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 714 718 714 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 775 777 775 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9D</xref>
###xml 832 836 832 836 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
To determine whether the diffuse band may contain Runx-1, the member of the Runx family shown to cooperate with Ets proteins, we performed supershift assays. The addition of the Runx-1 antibody to the binding reaction caused a loss of the diffuse band and the appearance of a supershifted complex (Fig. 9C). Thus, the identified Runx site in the LAT promoter is capable of binding Runx-1. To investigate the role of the Runx site in LAT promoter function, we introduced a point mutation within the putative Runx site in the context of the -1000 to -1 promoter construct and tested its activity in both Jurkat and RBL-2H3 cells. In contrast to our expectations, mutation of the Runx site resulted in an increase in LAT promoter function in both Jurkat and RBL-2H3 cells (Fig. 9D), implying that this site has an inhibitory effect on LAT promoter function.
###end p 41
###begin title 42
Discussion
###end title 42
###begin p 43
###xml 88 92 88 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 677 681 677 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 82 87 <span type="species:ncbi:9606">human</span>
This is the first study to examine the mechanisms regulating transcription of the human LAT gene. The data presented indicates that the gene contains numerous transcription start sites and that the proximal promoter extends approximately 800 bp upstream of the translation start site. Within the promoter we identified two Ets sites which when mutated dramatically reduced transcriptional activity. Both Ets sites were shown to bind Elf-1, and consistent with this finding, promoter activity was significantly augmented following Elf-1 overexpression. We also identified a binding site for Runx-1 that appears to suppress promoter activity. Finally, the absence of appreciable LAT promoter activity in 70Z and Raji B cell lines may contribute to the cell-type specific expression of this gene.
###end p 43
###begin p 44
###xml 109 113 109 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 508 512 508 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 844 848 844 848 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
Our results demonstrate that deletion of the region from -200 to -1 leads to a 3-fold or greater increase in LAT promoter activity. Since this region lies downstream of the transcription start sites, the effects observed could conceivably be mediated at the level of transcription or a subsequent step in the gene expression process, such as mRNA stability or the efficiency of translation. However, this region still possesses inhibitory activity when moved upstream of the transcription start sites in the LAT promoter (data not shown), suggesting that the effect occurs at the level of transcription. Although the biological relevance of the inhibitory region is presently unknown, the fact that the magnitude of its activity varies between Jurkat and RBL-2H3 cells suggests that it may modulate cell type specific expression levels for the LAT gene.
###end p 44
###begin p 45
###xml 124 128 124 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 290 294 290 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 570 572 570 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 573 575 573 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 822 824 819 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 825 827 822 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 909 910 906 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 1007 1011 1004 1008 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 881 886 <span type="species:ncbi:9606">human</span>
###xml 888 893 <span type="species:ncbi:10090">mouse</span>
###xml 899 902 <span type="species:ncbi:10116">rat</span>
Deletion analysis and linker scanning mutagenesis revealed that the region from -390 to -350 was particularly important for LAT promoter function. Within this region we identified two Ets sites and demonstrated that these sites bind the Ets transcription factor Elf-1. The finding that the LAT gene is regulated by Elf-1 is consistent with the known functions of Elf-1 and other members of this transcription factor family. Ets proteins have been shown to play a critical role in the development and function of T cells as well as other cell types of the immune system [25,26], and Elf-1 has been implicated in the regulation of a number of genes expressed in cells of hematopoietic origin, including genes for the TCRzeta chain, the CD4 co-receptor, the immunoglobulin heavy chain, the cytokine IL-2, and CD1D1 molecule [39-42]. The fact that both Ets sites are 100% conserved in human, mouse, and rat (Fig. 1 and data not shown) also suggests that these sites play a fundamental role in the regulation of LAT gene expression.
###end p 45
###begin p 46
###xml 187 188 187 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 490 492 490 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 493 495 493 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 496 498 496 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 719 721 712 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 722 724 715 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 773 775 766 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 159 164 <span type="species:ncbi:9606">human</span>
###xml 166 171 <span type="species:ncbi:10090">mouse</span>
###xml 177 180 <span type="species:ncbi:10116">rat</span>
Adjacent to the Ets site centered at -360 we identified a Runx site that is capable of binding Runx-1. Like the Ets sites, this Runx site is 100% conserved in human, mouse, and rat (Fig. 1 and data not shown). Similar to Ets, Runx family members have been shown to be critical for hematopoiesis and the expression of hematopoietic genes, where they positively or negatively regulate gene expression depending on the context of their binding site and/or prevailing intracellular conditions [30,31,43]. For example, during T cell development and/or in mature T cells, Runx family members positively regulate expression of the interleukin-3, granulocyte macrophage-colony stimulating factor, and TCR alpha and beta genes [44-47] while they inhibit expression of the CD4 gene [48].
###end p 46
###begin p 47
###xml 282 284 274 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 285 287 277 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 288 290 280 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 291 293 283 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 496 498 488 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 499 501 491 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 502 504 494 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 505 507 497 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 508 510 500 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 670 678 662 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 722 724 714 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 813 817 805 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 937 941 929 933 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 1155 1157 1147 1149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1223 1227 1215 1219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 1422 1426 1414 1418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 1441 1442 1433 1434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9</xref>
###xml 1588 1590 1580 1582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1591 1593 1583 1585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 1594 1596 1586 1588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 1631 1635 1623 1627 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 1890 1894 1882 1886 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
A number of genes contain promoter or enhancer elements with adjacent Ets and Runx binding sites, including the TCR alpha and beta enhancers, the osteopontin promoter, the immunoglobulin mu heavy chain enhancer, and the enhancers of the polyomavirus and the Moloney leukemia virus [33,34,49-52]. Both Runx and Ets proteins contain intramolecular inhibitory domains that can impede DNA binding and studies have shown that Runx-1 and certain members of the Ets family, namely Ets-1, MEF, and NERF [32,34,36-38,53], can interact with each other, displacing the inhibitory domains and thereby stimulating DNA binding and transactivation. Elf-1 has also been shown, at least in vitro, to be capable of interacting with Runx-1 [32]. Based on these findings, and the close proximity of the Ets and Runx sites within the LAT promoter, we hypothesized that the Runx site would behave similarly to the Ets site and contribute to the activation of LAT gene expression. However, our results revealed that the Runx site actually has a repressive effect on LAT promoter activity, a result analogous to the inhibitory role of Runx sites in the CD4 gene silencer region [30]. It is possible that Runx-1 does not interact with Elf-1 at the LAT promoter and thus no cooperative effects would be expected. Consistent with this possibility, our EMSA data demonstrate that Elf-1 and Runx-1 can independently bind their respective sites in the LAT promoter (Fig. 9). Runx proteins also interact with a number of other proteins that influence whether they have a positive or negative effect on gene expression [30,31,43]. Thus, Runx-1 may recruit to the LAT promoter proteins that actively inhibit gene expression. It is also possible that under different circumstances, for example during hematopoiesis or in other cell-types, members of the Runx and Ets families cooperatively bind to the adjacent sites in the LAT promoter to facilitate gene expression.
###end p 47
###begin p 48
###xml 30 34 30 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 113 117 113 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 196 200 196 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 416 420 416 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 534 535 534 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 798 800 798 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 801 803 801 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 912 915 912 915 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT</italic>
Our data from the analysis of LAT promoter activity in various cell-types is intriguing. The lack of significant LAT promoter activity in 70Z and Raji B cells, which do not express the endogenous LAT gene, suggests that the promoter region identified in this study may mediate cell-type specific expression of this gene. However, other mechanisms are likely to be involved in cell-type specific expression since the LAT promoter retains substantial activity in HeLa cells, another cell line that fails to express the endogenous gene [3]. In this latter situation, it is conceivable that chromatin structure may play a more predominate role in cell-type specific regulation. It should also be noted that since Elf-1 is expressed in B cells and has been shown to activate gene expression in B cells [39,54], it is unlikely that this transcription factor alone plays a central role cell-type specific expression of LAT.
###end p 48
###begin p 49
###xml 22 26 22 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 115 119 115 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 125 126 125 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 1069 1073 1069 1073 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 1222 1226 1222 1226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
The results analyzing LAT promoter function in Jurkat and RBL-2H3 cell lines, both of which express the endogenous LAT gene [3], indicates that functional differences exist. In particular, a promoter fragment spanning from -400 to -1 fails to support gene expression in the RBL-2H3 mast cell line. One possible explanation of this result is that the Ets sites do not exert a positive effect on gene expression in mast cells. However, our data indicates that this is not the case and instead points to another explanation, namely that the -200 to -1 region and the Runx sites have a greater suppressive effect in mast cells, and thereby may mitigate any positive contribution made by factors binding to the Ets sites. The results in RBL-2H3, Jurkat, and HeLa cells also indicate that additional regulatory elements exist in the region upstream of -400, and in particular in the region spanning from -450 to -400. We have identified a number of potential Sp-1 binding sites within this section of the promoter and are currently exploring the role these sites may play in LAT gene regulation (data not shown). This and additional research will further elucidate the role of various transcription factors in the regulation of LAT gene expression, and should provide further insights into the role each of these factors play in the cell-type specific expression of this gene.
###end p 49
###begin title 50
Conclusion
###end title 50
###begin p 51
###xml 89 93 89 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 486 490 486 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 575 579 575 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
The goal of this study was to investigate the mechanisms regulating transcription of the LAT gene, which is expressed in a number cell-types generated during hematopoiesis. We have defined the proximal promoter region and found binding sites for two families of transcription factors, Runx and Ets, which are known to play important roles in the development and function of hematopoietic cells. These sites are capable of binding Runx-1 and Elf-1 and appear to have opposing effects on LAT promoter function. These results provide initial insights into the regulation of the LAT gene and provide a framework for further research.
###end p 51
###begin title 52
Methods
###end title 52
###begin title 53
Cell lines
###end title 53
###begin p 54
###xml 83 88 <span type="species:ncbi:9606">human</span>
###xml 136 141 <span type="species:ncbi:10090">mouse</span>
###xml 172 177 <span type="species:ncbi:9606">human</span>
###xml 247 250 <span type="species:ncbi:10116">rat</span>
###xml 282 287 <span type="species:ncbi:9606">human</span>
###xml 382 386 <span type="species:ncbi:9913">calf</span>
All cell lines were obtained from the American Type Culture Collection. The Jurkat human acute Leukemia T cell line, the 70Z/3.12 (70Z) mouse pre-B cell line, and the Raji human lymphoblast-like B cell line were each grown in RPMI-1640 media. The rat RBL-2H3 mast cell line and the human HeLa epithelial cell line were grown in DMEM media. All media was supplemented with 10% fetal calf serum, penicillin, and streptomycin. The 70Z cell media also contained 50 muM beta-mercaptoethanol.
###end p 54
###begin title 55
Plasmids
###end title 55
###begin p 56
###xml 98 103 98 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NcoI </italic>
###xml 178 182 178 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 305 310 305 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KpnI </italic>
###xml 314 319 314 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NheI </italic>
###xml 424 429 424 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KpnI </italic>
###xml 433 438 433 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NheI </italic>
###xml 674 679 674 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NotI </italic>
###xml 803 807 803 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KpnI</italic>
###xml 808 812 808 812 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NotI</italic>
###xml 862 867 862 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KpnI </italic>
###xml 924 929 924 929 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NotI </italic>
###xml 1025 1030 1025 1030 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NotI </italic>
###xml 1088 1093 1088 1093 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NheI </italic>
###xml 1146 1151 1146 1151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KpnI </italic>
###xml 1155 1160 1155 1160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NotI </italic>
###xml 1163 1168 1163 1168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NotI </italic>
###xml 1172 1176 1172 1176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NheI</italic>
###xml 1202 1207 1202 1207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KpnI </italic>
###xml 1211 1216 1211 1216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NheI </italic>
###xml 30 35 <span type="species:ncbi:9606">human</span>
A pBAC plasmid containing the human LAT gene and the surrounding genomic region was digested with NcoI and a 3543 bp DNA fragment extending approximately 3200 bp upstream of the LAT translation start site was subcloned into pBluescript KS II+ (Stratagene). This plasmid and primers incorporating flanking KpnI and NheI restriction sites were used in PCR to generate putative promoter fragments that were then subcloned into KpnI and NheI digested pGL3-Basic plasmid (Promega Corp.). This placed the putative LAT promoter fragments immediately upstream of the firefly luciferase gene in pGL3-Basic. For linker scanning mutagenesis, sequential 10 bp mutations incorporating a NotI restriction site were constructed as follows: two fragments of the promoter region were generated by PCR. For one fragment (KpnI-NotI), the sense primer at -1000 contained a flanking KpnI restriction site while the anti-sense primer contained a NotI site spanning the region to be mutated. For the second fragment, the sense primer contained the NotI site and the anti-sense primer at -1 contained a flanking NheI site. PCR products were purified, then digested with KpnI and NotI or NotI and NheI, and finally cloned into KpnI and NheI digested pGL3-Basic.
###end p 56
###begin p 57
###xml 108 112 108 110 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 273 275 271 273 <underline xmlns:xlink="http://www.w3.org/1999/xlink">TT</underline>
###xml 273 275 271 273 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><underline>TT</underline></bold>
###xml 330 332 328 330 <underline xmlns:xlink="http://www.w3.org/1999/xlink">TT</underline>
###xml 330 332 328 330 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><underline>TT</underline></bold>
###xml 407 409 405 407 <underline xmlns:xlink="http://www.w3.org/1999/xlink">TT</underline>
###xml 407 409 405 407 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><underline>TT</underline></bold>
Site-directed mutatgenesis of the putative Ets and Runx DNA binding sites was conducted using the QuikChange(R) II Site-Directed Mutagenesis kit (Stratagene). The specific base pair changes were as follows: The Ets site centered at -390 was changed from GATTTCCTGC to GATTTTTTGC, the Runx site at -365 was changed from ACCACA to ATTACA, and the Ets site centered at -360 was changed from AGCTTCCTGC to AGCTTTTTGC. All plasmids created for these studies were sequenced to ensure that unwanted mutations were not incorporated during their construction.
###end p 57
###begin p 58
###xml 28 36 28 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Renilla </italic>
The internal control pRL-TK Renilla lucifierase vector and the pGL3-Control vectors were purchased from Promega Corp. The expression vectors pCB6-Elf-1, along with the parental pCB6 vector, were provided by Dr. Scott W. Hiebert, Vanderbilt University School of Medicine, Nashville, Tennessee.
###end p 58
###begin title 59
RLM-RACE
###end title 59
###begin p 60
###xml 101 105 101 103 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 604 608 602 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 790 794 788 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 277 281 <span type="species:ncbi:9913">calf</span>
###xml 361 368 <span type="species:ncbi:4097">Tobacco</span>
###xml 826 831 <span type="species:ncbi:9606">Human</span>
RNase Ligase-mediated Rapid Amplification of cDNA ends (RLM-RACE) was performed using the FirstChoice(R) RLM-RACE kit (Ambion, Inc). In this procedure, Poly(A) RNA was isolated from Jurkat T cells using the PolyATtract mRNA isolation System III (Promega Corp) and treated with calf intestinal phosphatase to remove the 5' phosphate from truncated mRNA species. Tobacco acid pyrophosphatase treatment then removed the 5' cap structure from full length RNA, followed by ligation of the 5' RACE adaptor. Reverse transcription followed by two rounds of PCR resulted in amplification of the 5' portion of the LAT cDNA. PCR products were separated by agarose gel electrophoresis, gel-purified, and cloned into pBluescript II KS+ for DNA sequencing. A similar series of steps were used to map the LAT transcription start sites using Human Thymus RACE-Ready cDNA (Ambion, Inc.).
###end p 60
###begin title 61
Transient transfection and Luciferase assay
###end title 61
###begin p 62
###xml 156 158 155 157 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 262 270 259 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Renilla </italic>
###xml 680 682 675 677 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 995 1003 987 995 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Renilla </italic>
###xml 1118 1126 1110 1118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Renilla </italic>
###xml 1373 1381 1365 1373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Renilla </italic>
###xml 1439 1443 1431 1435 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
Jurkat, RBL-2H3, and Raji cells were transiently transfected by electroporation at 950 muF and either 240 V (Jurkat, Raji) or 300 V (RBL-2H3) using 1-5 x 106 cells, 2.5 mug of pGL3 firefly luciferase reporter plasmid and 0.25 mug of the internal control phRG-TK Renilla luciferase plasmid per sample. HeLa cells were also transfected by electroporation as described above except for experiments involving the overexpression of Elf-1, in which case 4 mug of the parental pCB6 vector or Elf-1 expressing pCB6-Elf-1 was included. For all tranfections, pBluescript II KS+ plasmid DNA was also added to bring the final amount of DNA to 10 mug. 70Z cells were transfected using 2.5 x 105 cells, 0.9 mug of pGL3 reporter plasmid, 0.1 mug of phRG-TK plasmid, and 3 mul of FUGENE 6 reagent (Roche Applied Science) per sample according to the manufacturer's protocol. Following transfection, cells were resuspended in their respective media, incubated 20-24 hr, then harvested and assayed for firefly and Renilla luciferase activity using the Dual-Luciferase Reporter Assay System (Promega Corporation). The ratio of firefly to Renilla luciferase activity was calculated for each sample and the value obtained using the promoterless pGL3-basic vector was set at one-fold activation except for Elf-1 overexpression studies in HeLa cells. In these experiments, the ratio of firefly to Renilla luciferase activity obtained with the wild-type or mutEts LAT reporter constructs and pCB6 was set at one-fold activation.
###end p 62
###begin p 63
Duplicate or triplicate samples were included for all transfections and the average and standard error of the mean (s.e.m.) for each reporter plasmid or condition was calculated from three or more independent transfection experiments using at least two preparations of each test plasmid.
###end p 63
###begin title 64
Preparation of nuclear extracts and the electrophoretic mobility shift assay
###end title 64
###begin p 65
###xml 487 488 486 487 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
For the preparation of nuclear extracts, Jurkat T cells were washed once with PBS, then lysed in a buffer containing 10 mM HEPES, pH 7.6, 60 mM KCl, 1 mM EDTA, 0.075% NP-40, 1 mM DTT, 1 mM PMSF, 5 mug/ml each of aprotinin, leupeptin, and pepstatin. The resulting lysate was centrifuged at 1500 rpm for 4 min and the nuclear pellet washed once with lysis buffer lacking NP-40. The nuclear pellet was then resuspended in nuclear extract buffer (20 mM Tris, pH 8.0, 400 mM NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 0.5 mM PMSF, and 20% glycerol) and incubated on ice for 10 min. Centrifugation at 14 K rpm for 15 min followed, and the protein concentration in the resulting supernatant (nuclear extract) was determined by the Bio-Rad DC Protein Assay prior to storage at -80degreesC.
###end p 65
###begin p 66
###xml 4 6 4 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 206 208 202 204 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 466 468 462 464 <underline xmlns:xlink="http://www.w3.org/1999/xlink">TT</underline>
###xml 550 552 546 548 <underline xmlns:xlink="http://www.w3.org/1999/xlink">TT</underline>
###xml 653 655 649 651 <underline xmlns:xlink="http://www.w3.org/1999/xlink">TT</underline>
###xml 718 720 714 716 <underline xmlns:xlink="http://www.w3.org/1999/xlink">TT</underline>
###xml 770 772 766 768 <underline xmlns:xlink="http://www.w3.org/1999/xlink">TT</underline>
###xml 779 781 775 777 <underline xmlns:xlink="http://www.w3.org/1999/xlink">TT</underline>
###xml 871 872 867 868 <underline xmlns:xlink="http://www.w3.org/1999/xlink">A</underline>
###xml 1004 1006 1000 1002 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
The 32P labeled probes used in the electrophoretic gel mobility shift assay (EMSA) were prepared by filling in annealed oligonucleotides with the Klenow fragment of DNA polymerase in the presence of [alpha-32P]dCTP and other dNTPs followed by purification using NucTrap probe purification columns (Stratagene). The sequence of the probes used in EMSAs are as follows (mutations are underlined): -390 wt : 5'-GCTTGATGATTTCCTGCCCTCGCC-3'; -390 mut Ets: 5;-GCTTGATGATTTTTTGCCCTCGCC-3'; -360 wt: 5'-GGCACAGCTTCCTGCCGCAGGCC-3'; -360 mut Ets: 5'-GGCACAGCTTTTTGCCGCAGGCC-3'; Runx/-360 Ets wt: 5'-GCGCTCACCACAGCTTCCTGCCGCAGG-3'; Runx/-360Ets mutRunx: 5'-GCGCTCATTACAGCTTCCTGCCGCAGG-3'; Runx/-360Ets mutEts: 5'-GCGCTCACCACAGCTTTTTGCCGCAGG-3'; Runx/-360Ets mutEts/Runx: 5'-GCGCTCATTACAGCTTTTTGCCGCAGG-3'; consensus Ets: 5'-GATCTCGAGCAGGAAGTTCGA-3'; consensus mutEts: 5'-GATCTCGAGCAAGAAGTTCGA-3'. Note that the GG at the 5' end of the -360 Ets probe and the terminal C nucleotide at the 3' end were added to aid in 32P labeling.
###end p 66
###begin p 67
For EMSAs, 5 mug of nuclear extract was used in DNA binding reactions containing 10 mM HEPES, pH 7.6, 50 mM KCl, 1 mM EDTA, 1 mM DTT, 5% glycerol, and 0.2 mug sheared salmon sperm DNA. For competition experiments a 100-fold molar excess of unlabeled competitor DNA was also added, while for supershift experiments 1 mul of antibody was used. The Ets-1 (C-20), Ets-2 (H-140), Elf-1 (C-20), Fli-1 (C-19), and Runx1 (N-20) antibodies used in supershift experiments were purchased from Santa Cruz Biotechnology, Inc. Samples were incubated on ice for 15 min, 20 K cpm of labeled probe was then added, and samples incubated an additional 30 min prior to loading onto a 4.5% nondenaturing polyacrylamide gel. Samples were electrophoresed at 4degreesC and 20 mA using a 0.5x TBE running buffer. After the separation of complexes, the gel was dried and exposed overnight to Kodak Biomax film at -80degreesC using an intensifying screen.
###end p 67
###begin title 68
Accession numbers
###end title 68
###begin p 69
###xml 29 34 <span type="species:ncbi:9606">human</span>
###xml 36 41 <span type="species:ncbi:10090">mouse</span>
###xml 46 49 <span type="species:ncbi:10116">rat</span>
###xml 80 85 <span type="species:ncbi:9606">human</span>
###xml 97 102 <span type="species:ncbi:10090">mouse</span>
###xml 115 118 <span type="species:ncbi:10116">rat</span>
The accession number for the human, mouse and rat DNA sequences are: [GenBank:](human); [EMBL: ](mouse); [EMBL: ] (rat).
###end p 69
###begin title 70
Authors' contributions
###end title 70
###begin p 71
TF conceived the study, its design and coordination, and wrote the manuscript. TF, GJ, SP, and VH created the various reporter constructs and conducted the transient transfection experiments. TF and GJ carried the EMSA studies, and TF performed the RLM-RACE experiments.
###end p 71
###begin title 72
Acknowledgements
###end title 72
###begin p 73
The authors would like to thank Adeline Ashmore, Yuan Mei, Cindy Zheng, Jennilee Robinson, Emily Burnham, Kateena Johnson, and Hameeda Bello for their technical assistance, Sara Scherer and Dr. Douglas Fantz for their critical reading of the manuscript, and Dr. Scott W. Hiebert for the pCB6 and pCB6-Elf-1 expression vectors. The work is supported by a grant (MCB - 0234997) from the National Science Foundation.
###end p 73
###begin article-title 74
Signal transduction mediated by the T cell antigen receptor: The role of adapter proteins
###end article-title 74
###begin article-title 75
Transmembrane adaptor proteins: Organizers of immunoreceptor signalling
###end article-title 75
###begin article-title 76
LAT: The ZAP-70 tyrosine kinase substrate that links T cell receptor to cellular activation
###end article-title 76
###begin article-title 77
Molecular cloning of the cDNA encoding pp36, a tyrosine-phosphorylated adaptor protein selectively expressed by T cells and natural killer cells
###end article-title 77
###begin article-title 78
LAT is required for TCR-mediated activation of PLCgamma1 and the ras pathway
###end article-title 78
###begin article-title 79
Functional analysis of LAT in TCR-mediated signaling pathways using a LAT-deficient jurkat cell line
###end article-title 79
###begin article-title 80
Essential role of LAT in T cell development
###end article-title 80
###begin article-title 81
LAT is required for tyrosine phosphorylation of phospholipase cgamma2 and platelet activation by the collagen receptor GPVI
###end article-title 81
###begin article-title 82
###xml 52 57 <span type="species:ncbi:9606">human</span>
Cutting edge: A role for the adaptor protein LAT in human NK cell-mediated cytotoxicity
###end article-title 82
###begin article-title 83
LAT is essential for fc(epsilon)RI-mediated mast cell activation
###end article-title 83
###begin article-title 84
Differential requirement for LAT and SLP-76 in GPVI versus T cell receptor signaling
###end article-title 84
###begin article-title 85
2B4 is constitutively associated with linker for the activation of T cells in glycolipid-enriched microdomains: Properties required for 2B4 lytic function
###end article-title 85
###begin article-title 86
The molecular requirements for LAT-mediated differentiation and the role of LAT in limiting pre-B cell expansion
###end article-title 86
###begin article-title 87
LAT links the pre-BCR to calcium signaling
###end article-title 87
###begin article-title 88
Appearance of the LAT protein at an early stage of B-cell development and its possible role
###end article-title 88
###begin article-title 89
Linker for activation of T cells (LAT), a novel immunohistochemical marker for T cells, NK cells, mast cells, and megakaryocytes: Evaluation in normal and pathological conditions
###end article-title 89
###begin article-title 90
Oligo-capping: A simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides
###end article-title 90
###begin article-title 91
Revolutions in rapid amplification of cDNA ends: New strategies for polymerase chain reaction cloning of full-length cDNA ends
###end article-title 91
###begin article-title 92
The RNA polymerase II core promoter
###end article-title 92
###begin article-title 93
The TRANSFAC system on gene expression regulation
###end article-title 93
###begin article-title 94
MatInd and MatInspector: New fast and versatile tools for detection of consensus matches in nucleotide sequence data
###end article-title 94
###begin article-title 95
JASPAR: An open-access database for eukaryotic transcription factor binding profiles
###end article-title 95
###begin article-title 96
Ets target genes: Past, present and future
###end article-title 96
###begin article-title 97
Specificity within the ets family of transcription factors
###end article-title 97
###begin article-title 98
The ETS-domain transcription factor family
###end article-title 98
###begin article-title 99
Molecular biology of the ets family of transcription factors
###end article-title 99
###begin article-title 100
Expression profiles frame the promoter specificity dilemma of the ETS family of transcription factors
###end article-title 100
###begin article-title 101
Expression pattern of the ets-related transcription factor elf-1
###end article-title 101
###begin article-title 102
###xml 30 36 <span type="species:ncbi:10090">murine</span>
Cloning and expression of the murine elf-1 cDNA
###end article-title 102
###begin article-title 103
Mechanisms of transcriptional regulation by runt domain proteins
###end article-title 103
###begin article-title 104
Core-binding factors in hematopoiesis and immune function
###end article-title 104
###begin article-title 105
Functional and physical interactions between AML1 proteins and an ETS protein, MEF: Implications for the pathogenesis of t(8;21)-positive leukemias
###end article-title 105
###begin article-title 106
ETS-core binding factor: A common composite motif in antigen receptor gene enhancers
###end article-title 106
###begin article-title 107
Cooperative binding of ets-1 and core binding factor to DNA
###end article-title 107
###begin article-title 108
###xml 23 52 <span type="species:ncbi:11801">moloney murine leukemia virus</span>
Transactivation of the moloney murine leukemia virus and T-cell receptor beta-chain enhancers by cbf and ets requires intact binding sites for both proteins
###end article-title 108
###begin article-title 109
Auto-inhibition and partner proteins, core-binding factor beta (CBFbeta) and ets-1, modulate DNA binding by CBFalpha2 (AML1)
###end article-title 109
###begin article-title 110
Mutual activation of ets-1 and AML1 DNA binding by direct interaction of their autoinhibitory domains
###end article-title 110
###begin article-title 111
Auto-inhibition of ets-1 is counteracted by DNA binding cooperativity with core-binding factor alpha2
###end article-title 111
###begin article-title 112
Transcriptional regulation of CD1D1 by ets family transcription factors
###end article-title 112
###begin article-title 113
A potential role for elf-1 in CD4 promoter function
###end article-title 113
###begin article-title 114
Elf-1 regulates basal expression from the T cell antigen receptor zeta-chain gene promoter
###end article-title 114
###begin article-title 115
Cis-acting sequences required for inducible interleukin-2 enhancer function bind a novel ets-related protein, elf-1
###end article-title 115
###begin article-title 116
Upstream and downstream targets of RUNX proteins
###end article-title 116
###begin article-title 117
Positive and negative regulation of granulocyte-macrophage colony-stimulating factor promoter activity by AML1-related transcription factor, PEBP2
###end article-title 117
###begin article-title 118
###xml 43 48 <span type="species:ncbi:9606">human</span>
A conserved tissue-specific structure at a human T-cell receptor beta-chain core promoter
###end article-title 118
###begin article-title 119
###xml 38 43 <span type="species:ncbi:9606">human</span>
AML1A and AML1B can transactivate the human IL-3 promoter
###end article-title 119
###begin article-title 120
###xml 14 19 <span type="species:ncbi:10090">mouse</span>
PEBP2 alpha B/mouse AML1 consists of multiple isoforms that possess differential transactivation potentials
###end article-title 120
###begin article-title 121
Differential requirements for runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development
###end article-title 121
###begin article-title 122
###xml 41 47 <span type="species:ncbi:10090">murine</span>
###xml 85 114 <span type="species:ncbi:11801">moloney murine leukemia virus</span>
Identification of ETS domain proteins in murine T lymphocytes that interact with the moloney murine leukemia virus enhancer
###end article-title 122
###begin article-title 123
Distinct roles for P-CREB and LEF-1 in TCR alpha enhancer assembly and activation on chromatin templates in vitro
###end article-title 123
###begin article-title 124
Transcriptional regulation of osteopontin gene in vivo by PEBP2alphaA/CBFA1 and ETS1 in the skeletal tissues
###end article-title 124
###begin article-title 125
###xml 18 23 <span type="species:ncbi:10090">mouse</span>
Purification of a mouse nuclear factor that binds to both the A and B cores of the polyomavirus enhancer
###end article-title 125
###begin article-title 126
Isoforms of the ets transcription factor NERF/ELF-2 physically interact with AML1 and mediate opposing effects on AML1-mediated transcription of the B cell-specific blk gene
###end article-title 126
###begin article-title 127
ELF-1 interacts with and transactivates the IgH enhancer pi site
###end article-title 127
###begin title 128
Figures and Tables
###end title 128
###begin p 129
###xml 32 36 32 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 0 44 0 44 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A 450 bp region of the proximal <italic>LAT </italic>promoter</bold>
###xml 449 453 449 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 127 132 <span type="species:ncbi:9606">human</span>
###xml 173 178 <span type="species:ncbi:10090">mouse</span>
###xml 225 230 <span type="species:ncbi:9606">human</span>
###xml 235 240 <span type="species:ncbi:10090">mouse</span>
###xml 333 338 <span type="species:ncbi:9606">human</span>
###xml 540 545 <span type="species:ncbi:9606">human</span>
A 450 bp region of the proximal LAT promoter. The DNA sequence extending 450 bp upstream of the translation start site for the human gene and the homologous region from the mouse genome are shown. Bases conserved between the human and mouse are shaded. The 'A' nucleotide in the translation start site ATG codon (underlined) for the human sequence has been designated as +1 in this study. The transcription start sites identified for the endogenous LAT gene in Jurkat T cells have a '' above the site, those mapped using RNA isolated from human thymus have a '' above the site, and those that were identified in both Jurkat cells and thymus are indicated with a '' above the site. Potential binding sites for transcription factors of the Ets and Runx family are indicated with a bar above the site and the transcription factor name. Specific point mutations introduced into the -1000 to -1 promoter fragment are indicated below each site.
###end p 129
###begin p 130
###xml 40 44 40 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 0 60 0 60 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Mapping the 5' and 3' boundaries of the <italic>LAT </italic>promoter. A.-D. </bold>
###xml 253 257 253 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 327 335 327 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Renilla </italic>
###xml 484 492 484 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Renilla </italic>
###xml 752 756 752 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 905 909 905 909 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 247 252 <span type="species:ncbi:9606">human</span>
###xml 746 751 <span type="species:ncbi:9606">human</span>
Mapping the 5' and 3' boundaries of the LAT promoter. A.-D. Jurkat T cells were transiently transfected with a pGL3-basic firefly luciferase reporter vector containing various DNA fragments extending upstream of the translation start site for the human LAT gene. Cells were also co-transfected with the internal control pRL-TK Renilla luciferase plasmid. Following incubation, cells were harvested, luciferase activity was quantitiated and after normalization of each sample based on Renilla luciferase activity, the fold activation relative to the empty pGL3-basic vector was calculated. Results presented are the average fold induction and the standard error of the mean (s.e.m.) from three or more independent experiments. For each graph, the human LAT promoter fragments inserted into pGL3-basic are shown schematically on the left. Arrows depict the two clusters of transcription start sites for the LAT gene.
###end p 130
###begin p 131
###xml 62 66 62 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 0 76 0 76 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Linker scanning mutagenesis of the -450 to -351 region of the <italic>LAT </italic>promoter. </bold>
###xml 278 279 278 279 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 413 419 413 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not I </italic>
###xml 579 580 579 580 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 812 820 812 820 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Renilla </italic>
Linker scanning mutagenesis of the -450 to -351 region of the LAT promoter. Sequential 10 bp mutations were introduced throughout the -450 to -351 region in the context of the -1000 to -1 promoter fragment and the effects on promoter activity were determined in Jurkat T cells. A. The wild-type promoter sequence from -450 to -351 is shown on top. The lower strand depicts each 10 bp change, which incorporates a Not I restriction site (GCGGCCGC) plus one flanking nucleotide on each side. Base pair numbering is according to the translation start site, which was designated +1. B. Promoter activity for each linker scanning mutant was determined following transient transfection into Jurkat T cells. Following normalization of each sample based on the activity of co-transfected control pRL-TK plasmid encoding Renilla luciferase, the fold activation relative to empty pGL3-basic was calculated. The graph depicts the average fold activation and s.e.m. from three or more independent experiments.
###end p 131
###begin p 132
###xml 44 48 44 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 0 58 0 58 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effect of mutating the Ets sites within the <italic>LAT </italic>promoter. </bold>
Effect of mutating the Ets sites within the LAT promoter. Site-directed mutagenesis was used to mutate the Ets site centered at -360 (mutEts -360), the Ets site centered at -390 (mutEts -390), or both Ets sites (mutEts -360/-390). Mutations were introduced into the -1000 to -1 promoter fragment within the pGL3-basic vector. Specific base pair changes are shown in Fig. 1. Reporter plasmids were transiently transfected into Jurkat T cells and fold activation was determined as previously described. The results depict the average fold induction and s.e.m. from three or more independent experiments.
###end p 132
###begin p 133
###xml 65 69 65 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 0 82 0 82 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The transcription factor Elf-1 binds to the -360 Ets site in the <italic>LAT </italic>promoter. A. </bold>
###xml 168 170 168 170 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 839 840 839 840 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 956 959 956 959 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C. </bold>
The transcription factor Elf-1 binds to the -360 Ets site in the LAT promoter. A. A DNA probe encompassing the Ets site centered at -360 (-360 Ets wt) was labeled with 32P and incubated with nuclear extracts from Jurkat T cells in the absence or presence of 100-fold molar excess of competitor DNA. Samples were subsequently loaded onto a nondenaturing polyacrylamide gel, electrophoresed, and then subjected to autoradiography. For competition experiments, the unlabeled competitor DNA was the same sequence as that of the probe (self wt), the same sequence as the probe except containing point mutations within the Ets site (self mutEts), the consensus sequence for Ets family members (cons. wt) or the consensus sequence except for point mutations within the Ets site (cons. mutEts). The arrow indicates the specifically bound complex. B. Experiments were conducted as in Fig. 5A except that the indicated antibody was added in place of competitor DNA. C. A longer exposure of the lane containing the Elf-1 antibody. The supershifted complexes are indicated with arrows.
###end p 133
###begin p 134
###xml 0 43 0 43 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Elf-1 interacts with the -390 Ets site. A. </bold>
###xml 129 131 129 131 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 733 734 733 734 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
Elf-1 interacts with the -390 Ets site. A. A DNA probe encompassing the Ets site centered at -390 (-390 Ets wt) was labeled with 32P and incubated with nuclear extracts from Jurkat T cells in the absence or presence of 100-fold molar excess of competitor DNA. Samples were processed as described in the legend for Fig. 5. For competition experiments, the unlabeled competitor DNA was the same sequence as that of the probe (self wt), the same sequence as the probe except containing point mutations within the Ets site (self mutEts), the consensus sequence for Ets family members (cons. wt) or the consensus sequence except for point mutations within the Ets site (cons. mutEts). The arrows indicates the specifically bound complex. B. Experiments were conducted as in Fig. 5A except that the indicated antibody was added in place of competitor DNA.
###end p 134
###begin p 135
###xml 35 39 35 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 0 58 0 58 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Overexpression of Elf-1 stimulates <italic>LAT </italic>promoter activity. </bold>
###xml 137 141 137 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 797 799 797 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t </italic>
Overexpression of Elf-1 stimulates LAT promoter activity. The pGL3-basic reporter vector containing the -400 to -1 wt region (wt) of the LAT promoter or the -400 to -1 region with point mutations within both Ets sites (mutEts) were transiently transfected into HeLa cells in the presence of the parental pCB6 vector or the expression vector for Elf-1, pCB6-Elf-1. Twenty to twenty four hours later cells were harvested and fold activation was determined as described. The luciferase activity for each construct in the absence of co-transfected Elf-1 was then set at 1-fold. The resulted shown are the average fold induction and s.e.m. for at least three independent experiments. p < 0.05 for Elf-1 activation of the mutant promoter relative to that of wild-type as determined using the two-tailed t test.
###end p 135
###begin p 136
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 0 43 0 43 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>LAT </italic>promoter activity in various cell-types</bold>
###xml 45 48 45 48 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A. </bold>
###xml 259 267 259 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Renilla </italic>
###xml 409 412 409 412 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B. </bold>
###xml 675 683 675 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Renilla </italic>
###xml 844 846 844 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t </italic>
###xml 851 854 851 854 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C. </bold>
###xml 1043 1051 1043 1051 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Renilla </italic>
###xml 1356 1358 1356 1358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t </italic>
###xml 108 113 <span type="species:ncbi:9606">human</span>
LAT promoter activity in various cell-types. A. Reporter constructs containing the indicated regions of the human LAT promoter were transiently transfected into the indicated cell-types. Following incubation, samples were harvested and after normalization to Renilla luciferase activity fold activation was calculated relative to that obtained with the promoterless pGL3-basic vector which was set at 1-fold. B. RBL-2H3 cells were transiently transfected with either the wild-type -1000 to -1 reporter plasmid or reporter plasmids containing the -1000 to -1 fragment with the indicated site(s) mutated. Following incubation, samples were harvested and after normalization to Renilla luciferase activity, the activity obtained with the wild-type promoter was set at 100%. p < 0.05 for mutant reporters relative to wild-type using the two-tailed t test C. RBL-2H3 cells were transfected with the -1000 to -1 or -1000 to -200 reporter plasmids. Following incubation, samples were harversted, luciferase activities were measured and normalized to Renilla luciferase, and the activity obtained with empty pGL3-basic was set at 1-fold. For Fig. 8A-8C, the results shown are the average fold induction and s.e.m. from three or more independent experiments. For 8B and 8C, p < 0.05 for the mutant reporters relative to wild-type as determined using the two-tailed t test.
###end p 136
###begin p 137
###xml 44 48 44 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LAT </italic>
###xml 0 61 0 61 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The transcription factor Runx1 binds to the <italic>LAT </italic>promoter. A. </bold>
###xml 170 172 170 172 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 657 660 657 660 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B. </bold>
###xml 785 788 785 788 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C. </bold>
###xml 961 962 961 962 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 1229 1237 1229 1237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Renilla </italic>
###xml 1511 1513 1511 1513 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t </italic>
The transcription factor Runx1 binds to the LAT promoter. A. A DNA probe encompassing the Runx site and the Ets site centered at -360 (Runx/-360 Ets wt) was labeled with 32P and incubated with nuclear extracts from Jurkat T cells in the absence or presence of 100-fold molar excess of unlabeled competitor DNA. Samples were processed as described in the legend for Fig. 5. For competition experiments, the unlabeled competitor DNA was the same sequence as that of the labelled probe (self wt), the same sequence as the probe except containing point mutations within the Ets site (self mutEts), the Runx site (self mutRunx) or both sites (self mutEts/Runx). B. Experiments were conducted as in Fig. 9A, with the exception that the Elf-1 antibody was also added to the indicated sample. C. Experiments were conducted as described in Fig. 9A except that the Runx-1 antibody was added instead of unlabeled competitor. For A-C, the arrow denotes specific complexes. D. Jurkat and RBL-2H3 cells were transfected with the wild type -1000 to -1 reporter plasmid or the -1000 to -1 reporter plasmid with a mutation within the Runx site. Following incubation, samples were harversted, luciferase activities were measured and normalized to Renilla luciferase, and the activity obtained with empty pGL3-basic was set at 1-fold. The results shown are the average fold induction and s.e.m. from three or more independent experiments. p < 0.05 for the mutant reporters relative to wild-type as determined using the two-tailed t test.
###end p 137

